CompuMed (OTCMKTS:CMPD), Inc. (OTCMKTS:CMPD) is a global provider of advanced medical reporting software and telemedicine services, specializing in cardiology diagnostic solutions. Headquartered in Irvine, California, the company develops and markets CardioServer®, an integrated, web-based system for the acquisition, analysis, and reporting of cardiovascular studies. CardioServer® supports a range of modalities, including resting and stress electrocardiograms (ECG), Holter monitoring, event recording, and ambulatory blood pressure monitoring, enabling healthcare providers to streamline workflow and improve patient care.
In addition to its flagship CardioServer® platform, CompuMed offers a suite of ancillary products and services designed to enhance diagnostic accuracy and operational efficiency. Its Spirometry Server facilitates pulmonary function testing, while its Sleep Server supports sleep study acquisition and interpretation. The company also provides professional services such as installation, training, technical support and system customization to meet the needs of hospitals, clinics and diagnostic labs. This comprehensive offering allows customers to manage and interpret large volumes of cardiac and respiratory data from a single, centralized interface.
Founded in 1983, CompuMed has expanded its reach to more than 30 countries across North America, Europe, Asia and Latin America. Over its history, the firm has forged partnerships with leading medical device manufacturers and health systems to integrate its solutions into diverse clinical environments. Its cloud-based architecture and commitment to interoperability have positioned the company as a key player in the growing telehealth market, responding to the rising demand for remote diagnostics and virtual care models.
Under the leadership of its executive team and board of directors, CompuMed continues to invest in research and development, focusing on enhanced analytics, artificial intelligence-driven interpretation and secure data transmission. The company’s management emphasizes regulatory compliance and data privacy, ensuring that its platforms meet international standards such as ISO 13485 and HIPAA. As the telemedicine sector evolves, CompuMed remains dedicated to delivering innovative tools that support clinical decision-making and improve patient outcomes.
